Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio: 2012-2025

Historic Interest Coverage Ratio for Enanta Pharmaceuticals (ENTA) over the last 8 years, with Sep 2025 value amounting to -7.70.

  • Enanta Pharmaceuticals' Interest Coverage Ratio rose 33.41% to -7.70 in Q3 2025 from the same period last year, while for Sep 2025 it was -11.11, marking a year-over-year increase of 0.11%. This contributed to the annual value of -11.11 for FY2025, which is 0.11% up from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at -7.70 for Q3 2025, which was up 34.04% from -11.68 recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Interest Coverage Ratio high stood at -7.70 for Q3 2025, and its period low was -18.38 during Q2 2023.
  • Moreover, its 3-year median value for Interest Coverage Ratio was -11.62 (2024), whereas its average is -11.87.
  • Examining YoY changes over the last 5 years, Enanta Pharmaceuticals' Interest Coverage Ratio showed a top increase of 44.14% in 2024 and a maximum decrease of 18.36% in 2024.
  • Enanta Pharmaceuticals' Interest Coverage Ratio (Quarterly) stood at -10.14 in 2023, then fell by 18.36% to -12.00 in 2024, then skyrocketed by 33.41% to -7.70 in 2025.
  • Its Interest Coverage Ratio was -7.70 in Q3 2025, compared to -11.68 in Q2 2025 and -14.31 in Q1 2025.